. 2020 Apr 25;57(2):114–123. doi: 10.2141/jpsa.0180112

Table 4. Effect of treatments on blood constituents, blood chemistry, and thiobarbituric acid-reactive substances in the plasma (expressed as MDA levels)on day 43.

Observations	Treatments¹, ²					SEM	P-value
Observations	T1	T2	T3	T4	T5	SEM	P-value
Blood constituents
PCV³ (%)	31.5	30.9	31.1	28.1	31.3	0.514	0.181
WBC⁴ (cell/µL)	17,500	21,110	23,221	30,200	25,175	1,548	0.094
Heterophil (%)	41.3^ab	50.8^a	50.6^a	24.5^b	33.4^ab	2.719	0.003
Lymphocyte (%)	43.4^b	45.1^b	43.6^b	56.7^a	57.8^a	1.968	0.012
H/L ratio⁵	0.95^ab	1.13^a	1.17^a	0.44^b	0.59^b	0.076	0.001
Blood chemistry
Glucose (mg/dL)	212^a	201^a	198^ab	183^ab	162^b	4.892	0.005
Triglyceride (mg/dL)	38.6	32.6	26.7	24.1	26.8	4.892	0.056
Cholesterol (mg/dL)	124^a	130^a	129^a	107^ab	99.9^b	3.217	0.002
MDA⁶ (nmol/mL)	3.03	3.00	2.97	2.94	2.94	0.014	0.233

Treatments: T1 control, T2 avilamycin, T3 crude ethanol extract (CEE) of Jakr-Na-Rai (JNR) granules (0.13% flavonoid), T4 JNR powder (0.13% flavonoid), and T5 JNR powder (0.26% flavonoid).

Mean value from six replications per treatment.

Packed cell volume

⁴

White blood cell count

⁵

H/L ratio was calculated by dividing % Heterophils by % Lymphocytes.

⁶

Malondialdehyde concentrations

^a-b

Means in the same row with different superscript letters are significantly different (P<0.05).